As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs.
Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl.
The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across North America.
OBJ360 (Sponsored)
Growing the heart of Orléans – one business at a time
The Heart of Orléans Business Improvement Area (BIA) is a local board of Ottawa City Council, guided by a volunteer board of management and established in 2006. The BIA represents
Brigil shapes sustainable communities where people feel connected, valued, and at home
Since 1985, Brigil has redefined what it means to be at home by creating exceptional living environments combining quality, sustainability, and well-being. Founded by Gilles Desjardins, this family-owned business has
“We want this to be in the hands of everybody whose job it is to save lives in this crisis,” says company co-founder and CEO Malcolm Eade.
Learn more about Spectra Plasmonics by watching the full interview with Eade above.
